scispace - formally typeset
A

Arianna Carolina Rosa

Researcher at University of Turin

Publications -  44
Citations -  1354

Arianna Carolina Rosa is an academic researcher from University of Turin. The author has contributed to research in topics: Histamine & Receptor. The author has an hindex of 16, co-authored 41 publications receiving 1110 citations. Previous affiliations of Arianna Carolina Rosa include Durham University & University of Florence.

Papers
More filters
Journal ArticleDOI

Nanosponges as protein delivery systems: Insulin, a case study.

TL;DR: Preliminary results are encouraging with a view to continuing to study this β-cyclodextrin nanosponge technology for the oral administration of insulin and extending this approach to other proteins of pharmaceutical interest.
Journal ArticleDOI

Overexpression of histamine H4 receptors in the kidney of diabetic rat

TL;DR: It is demonstrated, for the first time, that the H4 receptor is expressed in the kidney mainly by resident renal cells of the loop of Henlé and that this receptor is significantly overexpressed in diabetic animals, thus suggesting a possible role in the pathogenesis of diabetes-associated renal disease.
Journal ArticleDOI

Histamine in diabetes: Is it time to reconsider?

TL;DR: An interesting upsurge in the field which provides scope for new insights into the role of histamine in diabetes is revealed.
Journal ArticleDOI

Prevention of Bleomycin-Induced Lung Inflammation and Fibrosis in Mice by Naproxen and JNJ7777120 Treatment

TL;DR: It is demonstrated that both JNJ7777120 and naproxen exert an anti-inflammatory and antifibrotic effect that is increased by their combination, which could be an effective therapeutic strategy in the treatment of pulmonary fibrosis.
Journal ArticleDOI

Strategies to expand the therapeutic potential of superoxide dismutase by exploiting delivery approaches.

TL;DR: This review intends to describe the rationale that underlie the various approaches and chemical strategies that have led to the most recent advances in SOD delivery, and includes SOD conjugates, SOD loaded into particulate carriers and the most promising and suitable formulations for oral delivery.